GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids
Y. Izuhara, H. Matsumoto, Y. Kanemitsu, K. Izuhara, Y. Tohda, T. Horiguchi, H. Kita, K. Kuwabara, T. Keisuke, K. Otsuka, M. Fujimura, N. Okura, K. Tomita, A. Yokoyama, H. Onishi, Y. Nakano, T. Oguma, S. Hozawa, T. Nagasaki, I. Ito, T. Oguma, H. Inoue, T. Tajiri, T. Iwata, J. Ono, S. Ohta, M. Tamari, T. Hirota, T. Yokoyama, A. Niimi, M. Mishima (Kyoto, Saga, Aichi, Osaka, Hyogo, Kanazawa, Kochi, Shiga, Hiroshima, Kanagawa, Yokohama, Saitama, Japan)
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Izuhara, H. Matsumoto, Y. Kanemitsu, K. Izuhara, Y. Tohda, T. Horiguchi, H. Kita, K. Kuwabara, T. Keisuke, K. Otsuka, M. Fujimura, N. Okura, K. Tomita, A. Yokoyama, H. Onishi, Y. Nakano, T. Oguma, S. Hozawa, T. Nagasaki, I. Ito, T. Oguma, H. Inoue, T. Tajiri, T. Iwata, J. Ono, S. Ohta, M. Tamari, T. Hirota, T. Yokoyama, A. Niimi, M. Mishima (Kyoto, Saga, Aichi, Osaka, Hyogo, Kanazawa, Kochi, Shiga, Hiroshima, Kanagawa, Yokohama, Saitama, Japan). GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids. Eur Respir J 2014; 44: Suppl. 58, 4777
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: